Liliya Mukhametzyanova was awarded the Commerzbank Foundation’s Dr Walter Seipp Prize for her dissertation on ‘Increasing the utility of evolved site-specific recombinases for genome editing’. With this award, the foundation honours Liliya’s excellent research work.
In her dissertation, written under the supervision of Prof Dr Frank Buchholz and completed with ‘summa cum laude’ in 2023, Liliya developed a new, pioneering method for correcting errors that can occur in genetic material with the utmost precision.
She presents a novel gene editing approach that combines tyrosine-specific recombinases with zinc finger DNA-binding domains. The results of this work led to both a patent and a first author publication in the renowned journal Nature Biotechnology.
After completing her doctorate at TU Dresden, Liliya moved to Seamless Therapeutics GmbH, a spin-off of our lab, where she has since continued to work on the development of recombinase technology as a senior scientist.